learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Learn how educating type 1 diabetic adults about hypoglycemia may help to achieve better health through physical activity.

HONG KONG, Sept. 17, 2024. Ascletis Pharma Inc. ("Ascletis") announces today completion of initial dosing in its two recently initiated U.S. Phase I...

When we discuss heart health for people with type 2 diabetes, the conversation often goes beyond the typical advice of improving diet and exercise. A...

When we discuss heart health for people with type 2 diabetes, the conversation often goes beyond the typical advice of improving diet and exercise. A...

TUESDAY, Sept. 17, 2024 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...